Critical Path Ventures Website, Blog & Press Pages

Critical Path Ventures Website, Blog & Press Pages - aVenture

Critical Path Ventures - Library

critical-path.frCrawled Oct 5, 2026

Blog

4 pages

Post/post/rds-l%C3%A8ve-14-millions-d-euros-pour-industrialiser-sonpatch-connect%C3%A9-de-suivi-des-patients-%C3%A0-distance
Post/post/sonomind-l%C3%A8ve-3-millions-d-euros-pour-traiter-la-d%C3%A9pression-gr%C3%A2ce-%C3%A0-la-neuromodulation
Post/post/alkion-bioinnovations-l%C3%A8ve-4-4-millions-d-euros-pour-industrialiser-la-production-durable-d-adjuvant
RDS raises €14 million to industrialize MultiSense®, aconnected patch for remote patient monitoring/en/post/rds-raises-14-million-to-industrialize-multisense-aconnected-patch-for-remote-patient-monitoring
Funds raised will help accelerate time to market in Europe for MultiSenseand scale industrial operations. Plans include starting a health economics study to support MultiSense’s reimbursement application, alongside preparing registration procedureswith US authorities, with an eye on US launch in 2028. Strasbourg, France, September 29, 2025 – RDS, a French medtech company, todayannounces a €14 million ($16.6M) Series A funding round. The SPI (Sociétés de ProjetsIndustriels) fund, managed on behal

Press

6 pages

Actualites/actualites
Actualites/en/actualites
Alkion BioInnovations raises €4.4 million to industrialize th sustainable production of QS-21 vaccine adjuvants and derivatives/en/post/alkion-bioinnovations-raises-4-4-million-to-industrialize-th-sustainable-production-of-qs-21-vaccin
Alkion BioInnovations, a biotechnology company, is developing an innovative plant-based bioproduction platform dedicated to active ingredients and saponin-based adjuvants for next-generation vaccines. By combining technological innovation, sustainability, and industrial sovereignty, Alkion provides a strategic response to major global health challenges. The company announces a €4.4 million financing round led by GO Capital and Critical Path Ventures.Paris, november 21, 2025 - This funding will s
BrainEver Secures €33 Million in Series B Funding to Advance ALSClinical Program/en/post/brainever-secures-33-million-in-series-b-funding-to-advance-alsclinical-program
Paris, July 3, 2025 – BrainEver, a biotechnology company focused on neurodegenerativediseases, today announced the successful completion of its €33 million Series B financinground. This funding will support the launch of the company’s first clinical trial in Europe forits lead therapeutic candidate targeting amyotrophic lateral sclerosis (ALS).The round was co-led by Critical Path Ventures and the European Innovation Council (EIC),with continued support from existing investors Ibionext and Relye

Homepage

2 pages

En/en
Since 2022, Critical Path Ventures has invested in innovative scientific research projects, providing financial support to deep-tech startups founded by researcher-entrepreneurs from the seed stage.
Homepage/
Since 2022, Critical Path Ventures has invested in innovative scientific research projects, providing financial support to deep-tech startups founded by researcher-entrepreneurs from the seed stage.

Coverage

6 items

Prophesee lève 20 millions et lance Mantara : un système de détection de dronesjaimelesstartups.fr/news/prophesee-levee-de-fonds-20-millions-systeme-detection-de-drones/
Prophesee raises €20 million in a round led by French fund Critical Path Ventures and unveils Mantara, an integrated drone-detection system. Mantara uses event-based sensing and embedded AI to detect drones.
Jun 2026 · J'aime les StartupsNews article
Sonomind stimule son capital en serie Acfnews.net/L-actualite/Capital-innovation/Operations/1er-tour/Sonomind-stimule-son-capital-en-serie-A-700139
Sonomind closes a Series A for its brain-stimulation device, with Critical Path Ventures investing alongside Bpifrance. The financing is intended to launch clinical testing.
May 2026 · CFNEWSNews article
Alkion BioInnovations lève 4.4 millions d'euros pour industrialiser la production durable d'adjuvants vaccinaux QS-21gazettelabo.fr/afrique/breves/18135Alkion-BioInnovations-QS21.html
Alkion BioInnovations raises €4.4 million to industrialize sustainable production of its QS-21 vaccine adjuvant. The round is led by GO Capital and Critical Path Ventures and will support scaling GMP production of the company’s QS-21 adjuvant platform.
Nov 2025 · Gazette du LaboratoireNews article
RDS Raises 14 Million EUR to Develop its Remote Patient Monitoring Toolmpo-mag.com/breaking-news/rds-raises-e14-million-to-develop-its-remote-patient-monitoring-tool/
RDS raises 14 million euros in Series A funding to develop its remote patient monitoring tool. Critical Path Ventures provides first-time support, and its Nicolas Foessel joins the RDS board alongside Bpifrance.
Oct 2025 · Medical Product OutsourcingNews article